Geode Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.6M | Buy |
|
|||||
|
2025
Q1 | $48.8M | Buy |
|
|||||
|
2024
Q4 | $47M | Buy |
|
|||||
|
2024
Q3 | $42.9M | Buy |
|
|||||
|
2024
Q2 | $34.2M | Buy |
|
|||||
|
2024
Q1 | $27.9M | Buy |
|
|||||
|
2023
Q4 | $26.5M | Buy |
|
|||||
|
2023
Q3 | $21.1M | Buy |
|
|||||
|
2023
Q2 | $24.6M | Buy |
|
|||||
|
2023
Q1 | $23.3M | Buy |
|
|||||
|
2022
Q4 | $20.1M | Sell |
|
|||||
|
2022
Q3 | $25M | Sell |
|
|||||
|
2022
Q2 | $25.9M | Sell |
|
|||||
|
2022
Q1 | $33.8M | Buy |
|
|||||
|
2021
Q4 | $44M | Buy |
|
|||||
|
2021
Q3 | $38.5M | Sell |
|
|||||
|
2021
Q2 | $36.4M | Buy |
|
|||||
|
2021
Q1 | $40.1M | Buy |
|
|||||
|
2020
Q4 | $23.3M | Buy |
|
|||||
|
2020
Q3 | $22.1M | Sell |
|
|||||
|
2020
Q2 | $26.9M | Sell |
|
|||||
|
2020
Q1 | $18.9M | Buy |
|
|||||
|
2019
Q4 | $26.1M | Sell |
|
|||||
|
2019
Q3 | $25.6M | Sell |
|
|||||
|
2019
Q2 | $29.9M | Buy |
|
|||||
|
2019
Q1 | $32.7M | Buy |
|
|||||
|
2018
Q4 | $33.7M | Buy |
|
|||||
|
2018
Q3 | $62.5M | Buy |
|
|||||
|
2018
Q2 | $45.7M | Buy |
|
|||||
|
2018
Q1 | $32.7M | Buy |
|
|||||
|
2017
Q4 | $26M | Buy |
|
|||||
|
2017
Q3 | $24.5M | Buy |
|
|||||
|
2017
Q2 | $21.6M | Buy |
|
|||||
|
2017
Q1 | $17.1M | Buy |
|
|||||
|
2016
Q4 | $15.7M | Buy |
|
|||||
|
2016
Q3 | $15.3M | Buy |
|
|||||
|
2016
Q2 | $17.4M | Buy |
|
|||||
|
2016
Q1 | $14.1K | Buy |
|
|||||
|
2015
Q4 | $14M | Buy |
|
|||||
|
2015
Q3 | $10.7M | Buy |
|
|||||
|
2015
Q2 | $12.6M | Buy |
|
|||||
|
2015
Q1 | $9.02M | Buy |
|
|||||
|
2014
Q4 | $6.14M | Sell |
|
|||||
|
2014
Q3 | $5.98M | Buy |
|
|||||
|
2014
Q2 | $7.18M | Sell |
|
|||||
|
2014
Q1 | $8.35M | Buy |
|
|||||
|
2013
Q4 | $5.26M | Buy |
|
|||||
|
2013
Q3 | $4.05M | Buy |
|
|||||
|
2013
Q2 | $3.31M | Buy |
|